Cancer Gene Therapy
Last updated ISSN 0929-1903
Cancer Gene Therapy is published by Springer Nature in biochemistry, genetics and molecular biology. It is a subscription journal. The article processing charge is $4,990.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Cancer Gene Therapy is — and show you journals like it.
What it publishes
Recent work in Cancer Gene Therapy concentrates on these topics, taken from its published record rather than from its own description:
- Virus-based gene therapy research
- RNA Interference and Gene Delivery
- CAR-T cell therapy research
- Immunotherapy and Immune Responses
- Cancer Research and Treatments
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- RNA modifications and cancer
- Viral Infectious Diseases and Gene Expression in Insects
- Immune Cell Function and Interaction
Key facts
| Publisher | Springer Nature |
|---|---|
| ISSN | 0929-1903, 1476-5500 |
| Subject area | Biochemistry, Genetics and Molecular Biology |
| Access | Subscription |
| Article processing charge | $4,990 |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 3,001 |
| Publishing since | 1992 |
| Journal website | www.nature.com/cgt/ |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Cancer Gene Therapy
Other established journals in biochemistry, genetics and molecular biology, if this one is not the right home for your paper: